Congenital syphilis is a serious but preventable disease that can be eliminated proactively through effective screening of all pregnant women for syphilis and treatment of those infected including their partner and newborn. In 2012, an estimated 930,000 maternal syphilis infections caused 350,000 adverse pregnancy outcomes, including 143,000 early fetal deaths/stillbirths, 62,000 neonatal deaths, 44,000 preterm/low weight births, and 102,000 infected infants. Nearly 80% of adverse outcomes (274,000) occurred among ANC attendees. From updated 2008 to 2012 estimates, maternal and congenital syphilis decreased by 38% (560,000 and 226,000 cases respectively). India represented 65% of the decline. Despite these declines, maternal syphilis still causes substantial adverse pregnancy outcomes, even among women attending ANC. Improving access to quality ANC, including syphilis testing and treatment, and surveillance are key to achieve EPTCT of syphilis as a public health problem. National STI guidelines for the treatment of syphilis in pregnancy specify the following:
• In the early stage, a single intramuscular injection of 2.4 million IU benzathine benzyl penicillin • In the late stage or if the duration is unknown, 3 weekly intramuscular injections of 2.4 million IU benzathine benzyl penicillin.
Alternative regimen for penicillin allergic pregnant patients includes:
• Early stage syphilis: Erythromycin, 500 mg orally, 4 times a day for 15 days • Late stage syphilis: Erythromycin, 500 mg orally, 4 times a day for 30 days.
All newborns born to syphilis-reactive pregnant women should either receive a prophylactic treatment (regimen 1) or a curative treatment (regimen 2).
PROPHYLACTIC TREATMENT (REGIMEN 1)
All asymptomatic infants with no serological evidence of syphilis and born to mothers who were adequately treated for maternal syphilis during current pregnancy 4 weeks prior to delivery should be treated with a single dose of benzathine penicillin G 50,000 units/kg given as a single intramuscular injection.
CURATIVE TREATMENT (REGIMEN 2)
It should be given to: • All symptomatic infants • All asymptomatic infants born to mothers who:
• Were treated with penicillin <4 weeks before delivery • Were treated with nonpenicillin regimens • Treatment status unknown • All infants fulfilling anyone of the following criteria: Whose RPR/VDRL titer is four-fold higher than that of the mother at delivery
• Born to mothers with clinical evidence of syphilis • Born to mothers whose RPR/VDRL titer did not drop four-fold • Having a rising RPR/VDRL titer.
Includes aqueous crystalline penicillin G 100,000-150,000 units/kg/day intravenously. It could be given as 50,000 units/kg/dose IV every 12 h during the first 7 days and thereafter every 8 h for next 3 days. Alternatively procaine penicillin 50,000 units/kg body weight can be given intramuscularly daily for 10 days.
Active participation of the members of Indian Association for the Study of Sexually Transmitted Diseases and AIDS will go a long way in achieving the goal of eliminating Congenital Syphilis from our country.
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